NEW YORK (GenomeWeb News) – Warnex has signed up Biron Laboratoire medical, a diagnostic and medical services provider in Quebec, to distribute its test for influenza A H1N1, Warnex said yesterday.
Warnex said Biron, which operates more than 100 sites throughout Quebec, will promote and distribute the test and will specifically target industrial companies as customers.
The Warnex test uses RT-PCR to detect the A H1N1 strain in as little as eight hours, the company said.
"With the possibility of a significant incidence rate of the pandemic A H1N1 flu virus this fall, companies are increasingly concerned with the effect this might have on their workforce," Warnex CEO and President Mark Busgang said in a statement.
Busgang also said that the diagnostic test will enable employees to receive diagnosis earlier, "allowing company decision makers to rapidly take appropriate action to limit the spread of infection to the rest of the workforce."
Terms of the agreement were not disclosed.